A China-based micro-cap biotechnology company focused on the development and commercialization of biological and health-related products. The firm has reported activities tied to research, production, and distribution of biotech-derived products aimed at healthcare and wellness markets. Investors te...
2 members of Congress have disclosed 11 trades in Park Ha Biological Technology Co., Ltd. (PHH), a Healthcare company. The buy/sell breakdown shows 4 purchases versus 7 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2016-02-29 | Seth Moulton | sell | $1K – $15K |
| 2014-02-19 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2014-02-19 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2014-02-14 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2014-02-13 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2014-01-28 | MICHAEL T. MCCAUL | sell | $15K – $50K |
| 2014-01-28 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2014-01-28 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2013-02-16 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2013-01-21 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2013-01-14 | MICHAEL T. MCCAUL | sell | $1K – $15K |